ANI Pharmaceuticals Inc (ANIP)
64.90
+1.44
(+2.27%)
USD |
NASDAQ |
May 31, 16:00
64.95
+0.05
(+0.08%)
After-Hours: 20:00
ANI Pharmaceuticals Total Assets (Quarterly): 914.52M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 914.52M |
December 31, 2023 | 904.42M |
September 30, 2023 | 889.91M |
June 30, 2023 | 859.34M |
March 31, 2023 | 765.22M |
December 31, 2022 | 760.09M |
September 30, 2022 | 739.11M |
June 30, 2022 | 751.33M |
March 31, 2022 | 744.85M |
December 31, 2021 | 771.60M |
September 30, 2021 | 470.45M |
June 30, 2021 | 480.16M |
March 31, 2021 | 463.84M |
December 31, 2020 | 461.19M |
September 30, 2020 | 462.58M |
June 30, 2020 | 465.39M |
March 31, 2020 | 482.23M |
December 31, 2019 | 456.79M |
September 30, 2019 | 456.78M |
June 30, 2019 | 446.91M |
March 31, 2019 | 434.39M |
December 31, 2018 | 430.60M |
September 30, 2018 | 439.44M |
June 30, 2018 | 424.18M |
March 31, 2018 | 418.02M |
Date | Value |
---|---|
December 31, 2017 | 412.14M |
September 30, 2017 | 370.47M |
June 30, 2017 | 359.22M |
March 31, 2017 | 357.14M |
December 31, 2016 | 322.86M |
September 30, 2016 | 319.38M |
June 30, 2016 | 308.00M |
March 31, 2016 | 291.59M |
December 31, 2015 | 285.26M |
September 30, 2015 | 283.28M |
June 30, 2015 | 270.12M |
March 31, 2015 | 265.98M |
December 31, 2014 | 259.56M |
September 30, 2014 | 107.64M |
June 30, 2014 | 95.42M |
March 31, 2014 | 96.65M |
December 31, 2013 | 44.50M |
September 30, 2013 | 43.29M |
June 30, 2013 | 41.66M |
March 31, 2013 | 35.36M |
December 31, 2012 | 38.77M |
September 30, 2012 | 43.21M |
June 30, 2012 | 47.29M |
March 31, 2012 | 54.57M |
December 31, 2011 | 62.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
446.91M
Minimum
Jun 2019
914.52M
Maximum
Mar 2024
637.34M
Average
610.67M
Median
Total Assets (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 913.87M |
ADMA Biologics Inc | 350.88M |
Annovis Bio Inc | 7.813M |
United Therapeutics Corp | 6.495B |
Moderna Inc | 16.73B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 437.71M |
Shareholders Equity (Quarterly) | 476.81M |
Debt to Equity Ratio | 0.5987 |
Current Ratio | 3.949 |
Net Debt Paydown Yield | 0.01% |